DrugDomain logoDrugDomain

5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-[2-[[20-[2-[5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]ethanoylamino]-2$l^{3},4,12,14$l^{3},16,24,25$l^{3},27$l^{3}-octathia-1$l^{4},3$l^{4},13$l^{4},15$l^{4}-tetraferranonacyclo[11.11.1.1^{1,13}.1^{6,10}.1^{18,22}.0^{2,15}.0^{3,14}.0^{3,25}.0^{15,27}]octacosa-6(28),7,9,18,20,22(26)-hexaen-8-yl]amino]-2-oxidanylidene-ethyl]pentanamide

P22629 Streptavidin

← Back

ECOD Domain Annotations

ECOD domains from AlphaFold model interacting with ligand NUI

UniProtDrugBankPDB LigandDomain LabelECOD IDX GroupH GroupT GroupF Group
No predicted ECOD data found

ECOD domains from experimental PDB structures interacting with ligand NUI

UniProtDrugBankPDB IDLigand Acc.ChainRes No.Exp. DomainX GroupH GroupT GroupF Group
P22629n/a8aqoNUIA201e8aqoA1Lipocalins/StreptavidinAvidin/StreptavidinAvidin/StreptavidinAvidin
P22629n/a8aqoNUIA201e8aqoD1Lipocalins/StreptavidinAvidin/StreptavidinAvidin/StreptavidinAvidin
P22629n/a8aqoNUIC201e8aqoB1Lipocalins/StreptavidinAvidin/StreptavidinAvidin/StreptavidinAvidin
P22629n/a8aqoNUIC201e8aqoC1Lipocalins/StreptavidinAvidin/StreptavidinAvidin/StreptavidinAvidin